跳到內容

跳到副選單

耶和華見證人

中文繁體(國語)

兒童乙型地中海貧血

輕度和中度乙型地中海貧血——經由藥物誘導體內胎兒血紅蛋白的合成

Optimizing the dose of hydroxyurea therapy for patients with β-thalassemia intermedia (Hb E-β-thalassemia): a single center study from eastern India.

Bohara VV, Ray S, Chakrabarti P, Ray SS, Nath UK, Chaudhuri U.

出處‎: Hemoglobin. 2014;38(1):44-8.

檢索‎: PubMed 24144212

DOI碼‎: 10.3109/03630269.2013.845844

http://www.ncbi.nlm.nih.gov/pubmed/24144212

Therapeutic superiority and safety of combined hydroxyurea with recombinant human erythropoietin over hydroxyurea in young β-thalassemia intermedia patients.

Elalfy MS, Adly AA, Ismail EA, Elhenawy YI, Elghamry IR.

出處‎: Eur J Haematol 2013;91(6):522-33.

檢索‎: PubMed 23927461

DOI碼‎: 10.1111/ejh.12182

http://www.ncbi.nlm.nih.gov/pubmed/23927461

A randomized phase I/II trial of HQK-1001, an oral fetal globin gene inducer, in β-thalassaemia intermedia and HbE/β-thalassaemia.

Fucharoen S, Inati A, Siritanaratku N, Thein SL, Wargin WC, Koussa S, Taher A, Chaneim N, Boosalis M, Berenson R, Perrine SP.

出處‎: Br J Haematol 2013;161(4):587-93.

檢索‎: PubMed 23530969

DOI碼‎: 10.1111/bjh.12304

http://www.ncbi.nlm.nih.gov/pubmed/23530969

Butyric acid: what is the future for this old substance?

Sossai P.

出處‎: Swiss Med Wkly 2012;142:w13596.

檢索‎: PubMed 22674349

DOI碼‎: 10.4414/smw.2012.13596

http://www.ncbi.nlm.nih.gov/pubmed/22674349

The emerging role of fetal hemoglobin induction in non-transfusion-dependent thalassemia.

Thein SL.

出處‎: Blood Rev 2012;26 Suppl 1:S35-9.

檢索‎: PubMed 22631042

DOI碼‎: 10.1016/S0268-960X(12)70011-5

http://www.ncbi.nlm.nih.gov/pubmed/22631042

Darbepoetin alfa for the treatment of anaemia in alpha- or beta- thalassaemia intermedia syndromes.

Singer ST, Vichinsky EP, Sweeters N, Rachmilewitz E.

出處‎: Br J Haematol 2011;154(2):281-4.

檢索‎: PubMed 21496003

DOI碼‎: 10.1111/j.1365-2141.2011.08617.x

http://www.ncbi.nlm.nih.gov/pubmed/21496003

Effect of hydroxyurea on the transfusion requirements in patients with severe HbE-beta-thalassaemia: a genotypic and phenotypic study.

Italia KY, Jijina FF, Merchant R, Panjwani S, Nadkarni AH, Sawant PM, Nair SB, Ghosh K, Colah RB.

出處‎: J Clin Pathol 2010;63(2):147-50.

檢索‎: PubMed 20154037

DOI碼‎: 10.1136/jcp.2009.070391

http://www.ncbi.nlm.nih.gov/pubmed/20154037

Effect of combination therapy of hydroxyurea with l-carnitine and magnesium chloride on hematologic parameters and cardiac function of patients with beta-thalassemia intermedia.

Karimi M, Mohammadi F, Behmanesh F, Samani SM, Borzouee M, Amoozgar H, Haghpanah S.

出處‎: Eur J Haematol 2010;84(1):52-8.

檢索‎: PubMed 19799627

DOI碼‎: 10.1111/j.1600-0609.2009.01356.x

http://www.ncbi.nlm.nih.gov/pubmed/19799627

Echocardiographic finding in beta-thalassemia intermedia and major: absence of pulmonary hypertension following hydroxyurea treatment in beta-thalassemia intermedia.

Karimi M, Borzouee M, Mehrabani A, Cohan N.

出處‎: Eur J Haematol 2009;82(3):213-8.

檢索‎: PubMed 19077048

DOI碼‎: 10.1111/j.1600-0609.2008.01192.x

http://www.ncbi.nlm.nih.gov/pubmed/19077048

Fetal hemoglobin inducers from the natural world: a novel approach for identification of drugs for the treatment of {beta}-thalassemia and sickle-cell anemia.

Bianchi N, Zuccato C, Lampronti I, Borgatti M, Gambari R.

出處‎: Evid Based Complement Alternat Med 2009;6(2):141-51.

檢索‎: PubMed 18955291

DOI碼‎: 10.1093/ecam/nem139

http://www.ncbi.nlm.nih.gov/pubmed/18955291

Single and combination drug therapy for fetal hemoglobin augmentation in hemoglobin E-beta 0-thalassemia: Considerations for treatment.

Singer ST, Kuypers FA, Olivieri NF, Weatherall DJ, Mignacca R, Coates TD, Davies S, Sweeters N, Vichinsky EP.

出處‎: Ann N Y Acad Sci 2005;1054:250-6.

檢索‎: PubMed 16339672

http://www.ncbi.nlm.nih.gov/pubmed/16339672

Hematologic and clinical responses of thalassemia intermedia patients to hydroxyurea during 6 years of therapy in Iran.

Karimi M, Darzi H, Yavarian M.

出處‎: J Pediatr Hematol Oncol 2005;27(7):380-5.

檢索‎: PubMed 16012328

http://www.ncbi.nlm.nih.gov/pubmed/16012328

Hydroxyurea in thalassemia intermedia--a promising therapy.

Dixit A, Chatterjee TC, Mishra P, Choudhry DR, Mahapatra M, Tyagi S, Kabra M, Saxena R, Choudhry VP.

出處‎: Ann Hematol 2005;84(7):441-6.

檢索‎: PubMed 15838670

http://www.ncbi.nlm.nih.gov/pubmed/15838670


JW.ORG​網站​內​的​醫療​資訊​主要​是​提供​給​醫生​及​醫療人員​參考,而​不​是​要​提供​診斷​建議​或​推薦​某​種​醫療​方法,也​不​是​要​取代​專業​的​醫療​護理。網站​上​引用​的​許多​醫學​文章​都​不​是​耶和華見證人​出版​的,但​當​中​提​到​了​許多​替代​輸​血​的​療法,這些​醫療​策略​很​值得​醫生​參考。每​一​個​專業​醫療人員​都​有​責任​經常​吸收​最​新​的​醫療​資訊,討論​最​適合​病人​的​醫療​方法。他們​也​要​根據​病人​的​病情、意願、價值觀​和​信仰​來​協助​病人​選擇​最佳​的​醫療​方式。本​網站​所​提供​的​醫療​策略​不​一定​適用​於​每​一​個​病人。

給​病人​的​建議:當​你​感到​身體​不適,要​立刻​尋求​醫生​的​幫助,也​要​聽取​醫生​以及​其他​專業​醫療人員​的​建議。

使用​本​網站​即​表示​你​接受​本使用​條款的​全部​內容。